Eric dEsparbes - 15 Aug 2023 Form 4 Insider Report for BIORA THERAPEUTICS, INC. (BIORQ)

Role
Chief Financial Officer
Signature
/s/ Clarke Neumann, Attorney-in-Fact for Eric d'Esparbes
Issuer symbol
BIORQ
Transactions as of
15 Aug 2023
Net transactions value
-$125,669
Form type
4
Filing time
17 Aug 2023, 16:22:47 UTC
Previous filing
17 May 2023
Next filing
15 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BIOR Common Stock Tax liability $125,669 -40,022 -40% $3.14 59,012 15 Aug 2023 Direct F1
transaction BIOR Common Stock Award $0 +219,650 +372% $0.000000 278,662 15 Aug 2023 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs.
F2 Consists of 219,650 restricted stock units, 25% of which will vest on August 15, 2024, with the remaining shares vesting in equal semi-annual installments through August 15, 2027, subject to the Reporting Person's continued service to the Issuer.